BPI e.V. Ordentliche Hauptversammlung 2020 - Öffentlicher Teil

Dr. Kai Joachimsen is the Director General of the German Pharmaceutical Industry Association (BPI e.V.) since January 2019.  Prior to this, Dr. Kai Joachimsen held several leading positions in the pharmaceutical Industry. Dr. Joachimsen completed his medical studies in Münster, Vienna and Marburg and obtained his PhD (magna cum laude). He also holds an Masters in Business Administration (MBA) from the North Western University (Kellogg School of Management).  

Dr. Hans-Georg Feldmeier is currently CEO of Dermapharm SE, a leading German Pharmaceutical company. Its business focusses on branded health care products, herbal extracts and parallel import. In addition, he is Managing Director of several Dermapharm subsidiaries. Hans has been Managing Director of Mibe GmbH Arzneimittel, the main factory of Dermapharm Group, from 2003 to 2009. Before this, he worked for 14 years for Berlin-Chemie AG / Menarini Group. Hans Feldmeier studied pharmacy at the University of Greifswald and received his doctorate from the Humboldt University of Berlin in 1991. He is Board Member of the German Pharmaceutical Industry Association (BPI).